Brookfield Asset Management (TSX:BAM) has struck a deal with Healthpeak Properties to create a joint venture targeting outpatient medical buildings across the United States. Under the agreement, Healthpeak will hold a 51% controlling stake and act as managing member, while Brookfield and its affiliates take the remaining 49% interest.
Healthpeak contributed a portfolio of 86 properties valued at approximately $2.1 billion, receiving gross proceeds of about $1.03 billion for the minority stake sale. The portfolio spans 11 states including Kentucky, Indiana, Pennsylvania, Illinois, Minnesota, New Jersey and New York, is 95% leased, and carries a weighted average remaining lease term of roughly six years.
Behind the transaction, some long-term investors are paying closer attention to Brookfield Asset Management itself — a company increasingly viewed as a cash-generative compounder worth holding for decades.
The investment case rests on an exceptionally clean balance sheet and sustainable shareholder returns. BAM operates with a debt-to-equity ratio of just 16.3%, leaving it virtually debt-free. Profitability metrics are equally compelling: a 71% gross margin, a 50% net margin, and a free cash flow margin as high as 57.5% all point to powerful cash generation. A 31.4% return on equity and 15.4% return on total capital further illustrate how efficiently the firm puts its capital to work.
These numbers are underpinned by an asset-light, fee-based business model. With more than $1 trillion in assets under management, predominantly from institutional clients such as pension funds and governments, Brookfield enjoys a steady stream of fee-related earnings. Off the balance sheet, the firm holds $67 billion in committed but undeployed capital. Once put to work, this dry powder should meaningfully boost fee-related profits.
Another durable advantage is Brookfield’s deeply embedded relationship network. Situated within the broader Brookfield ecosystem, the company has access to a vast pool of potential investors, ranging from major technology companies to sovereign governments. Bruce Flatt, a senior figure at the Brookfield corporate level, does not directly oversee BAM’s fund operations. Yet his connections with global political and business leaders — including meetings with Donald Trump during his presidency to discuss nuclear power projects — can indirectly assist capital-raising efforts.
For income-oriented investors, BAM currently offers a dividend yield of around 4%. While the stock trades at approximately 30 times conventional earnings, the multiple based on distributable earnings — a metric that better reflects the firm’s capacity to pay dividends — is markedly lower. This suggests little immediate risk to the payout. With negligible leverage, high cash conversion, and a robust fundraising pipeline, Brookfield Asset Management possesses the structural traits many look for in a multi-decade holding. The outpatient medical building deal is merely the latest footnote in a much larger investment story.
